Close Menu

NEW YORK ­– The US Food and Drug Administration said Friday evening that it has reissued an Emergency Use Authorization for Laboratory Corporation of America's COVID-19 RT-PCR Test for testing the broad population, even if they are asymptomatic, and for pooled testing for SARS-CoV-2, the virus that causes COVID-19.

The FDA reissued the EUA for the new uses after LabCorp provided data showing the test could detect SARS-CoV-2 in a general asymptomatic population, the agency said. LabCorp originally received EUA for the test in March.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

In Science this week: chromatin accessibility of microglia during fetal development, and more.